About Arbor Biosciences
Arbor Biosciences is a Healthcare company based in Detroit (United States) founded in 2006 by Erdogan Gulari and Jean-Marie Rouillard, and was acquired by Chiral Technologies in January 2019. DNA analysis microarrays are provided by Arbor Biosciences. Its website arborbiosci.com draws about 14 thousand monthly visits. Arbor Biosciences offers products and services including myBaits Custom Hybridization Capture Kits, myBaits Predesigned Kits, myTXTL Pro Kit, myTags Custom Probes, and Sequencing Services. Its focus areas include Life Sciences, Clinical Genomics, Hybridization Based and Microarrays. Its legal entity is Biodiscovery LLC. Its competitors include Inflammatix, Agendia and PathogenDX; 3 of its 3 listed competitors have raised funding.
Company details
Arbor Biosciences was founded in 2006 and is based in Detroit, United States. Operations focus on the biotechnology sector, where microarrays for DNA analysis are developed and supplied. The portfolio encompasses custom-designed microarrays known as myArray, in-solution target enrichment via myBaits, customizable DNA through myCRISPR, error-free DNA with myDNA, and oligonucleotide library synthesis using myLib. These offerings support applications in agrigenomics, cell-free protein expression, genome editing, paleogenetics, and phylogenetics.
- Headquarters Detroit, United States
- Founders Erdogan Gulari, Jean-Marie Rouillard
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website arborbiosci.com
- Social LinkedIn X Facebook
- Acquired by Chiral Technologies (Jan 2019)
- Legal Name Biodiscovery Llc
- Latest Funding Round$1.41M (USD), Grant
Sep 2012
- InvestorsHHS
& 2 more
- Acquired byChiral Technologies
(Jan 2019)
Products & Services of Arbor Biosciences
Arbor Biosciences offers a comprehensive portfolio of products and services, including myBaits Custom Hybridization Capture Kits, myBaits Predesigned Kits, myTXTL Pro Kit, myTags Custom Probes, and Sequencing Services.
Kits for custom capture in sequencing applications
Pre-designed kits for specific sequencing needs
Kit for protein synthesis in research contexts
Probes for in situ hybridization techniques
Services for DNA sequencing and analysis support
Funding Insights of Arbor Biosciences
- Total Rounds 7
- Last Round Grant — $1.41M
- First Round $1M
(Sep 2006)
- Investors Count 1
All 7 funding rounds of Arbor Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
3 investors in total: 3 institutional.
Investors in Arbor Biosciences
Arbor Biosciences has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, Daicel and Chiral Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Specialty chemicals are produced by Daicel in Japan since 1919. | 1919 | daicel.com | Minato City, Japan | |
Advanced chirality products and custom purification services | 1990 | chiraltech.com | West Chester, United States |
Investor details for Arbor Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Arbor Biosciences
8 people are tracked at Arbor Biosciences (5 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Erdogan Gulari | Co-Founder & Managing Partner | Leadership |
Jean-Marie Rouillard | Co-Founder & CSO | Leadership |
Jacob Enk | Director Of Technical Customer Success & Business Development | Leadership |
Joseph M. Barendt | President | Leadership |
Amy Hagar | Global Marketing Director | Leadership |
Heather Sayer | Customer Care Specialist | Team |
Danielle K. | Marketing Associate | Team |
Carrie Kleinle | Marketing Manager | Team |
Complete people profiles for Arbor Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Arbor Biosciences
4 dated milestones of Arbor Biosciences across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Arbor Biosciences is founded.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Grant, of $1.4M.
- Exit Acquired by Chiral Technologies.
Competitors of Arbor Biosciences
Arbor Biosciences has 3 listed competitors in our database, 3 of them funded. They include Inflammatix, Agendia and PathogenDX.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inflammatix.com | 2016 | San Francisco, United States | $191.47M | 54 | Provider of diagnostic solutions for systemic infections | |
| agendia.com | 2003 | Irvine, United States | $123M | 203 | Genomic diagnostic products for cancer treatment are provided. | |
| pathogendx.com | 2014 | Tucson, United States | $11.58M | 31 | Provider of DNA-based pathogen testing kits |
Detailed competitors of Arbor Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Arbor Biosciences
The website of Arbor Biosciences (arborbiosci.com) receives about 14.3K visits a month.
- Monthly visits14.3K
▼ 18.5% vs previous month
Websites whose visitors overlap most with Arbor Biosciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
nesvilab.org | nesvilab.org | 100% | #1,638,513 | – | |
| activemotif.com | 80% | 57.6K | #613,526 | View details | |
| neb.com | 65% | 749.5K | #69,042 | View details | |
| msbioworks.com | 24% | 10.4K | #2,756,535 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Arbor Biosciences (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Arbor Biosciences
Complete news archive for Arbor Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arbor Biosciences
Arbor Biosciences was founded in 2006.
Arbor Biosciences is headquartered in Detroit, United States. It is registered at Detroit, Michigan, United States.
Arbor Biosciences was founded in 2006 and is based in Detroit, United States. Operations focus on the biotechnology sector, where microarrays for DNA analysis are developed and supplied. The portfolio encompasses custom-designed microarrays known as myArray, in-solution target enrichment via myBaits, customizable DNA through myCRISPR, error-free DNA with myDNA, and oligonucleotide library synthesis using myLib. These offerings support applications in agrigenomics, cell-free protein expression, genome editing, paleogenetics, and phylogenetics.
Arbor Biosciences's top competitors include Inflammatix, PathogenDX and Agendia.
Arbor Biosciences offers myBaits Custom Hybridization Capture Kits, myBaits Predesigned Kits, myTXTL Pro Kit, myTags Custom Probes, and Sequencing Services.
Arbor Biosciences has 3 investors. Key investors include HHS, Daicel, and Chiral Technologies.
Arbor Biosciences operates through Biodiscovery Llc.
Yes. Arbor Biosciences was acquired by Chiral Technologies in January 2019.